Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy ; volume:13 ; number:1 ; day:2 ; month:2 ; year:2011 ; pages:1-2 ; date:12.2011
Journal of cardiovascular magnetic resonance ; 13, Heft 1 (2.2.2011), 1-2, 12.2011
- Creator
-
Tham, Edythe B.
- Contributor
-
Chow, Kelvin
Spavor, Maria
Pagano, Joseph J.
Haykowsky, Mark
Thompson, Richard
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-13-S1-P276
- URN
-
urn:nbn:de:1111-2016032217309
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tham, Edythe B.
- Chow, Kelvin
- Spavor, Maria
- Pagano, Joseph J.
- Haykowsky, Mark
- Thompson, Richard
- SpringerLink (Online service)
Other Objects (12)
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Staging and resilience degree in breast cancer survivors
Staging and resilience degree in breast cancer survivors
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Staging and resilience degree in breast cancer survivors
Staging and resilience degree in breast cancer survivors
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Staging and resilience degree in breast cancer survivors
Staging and resilience degree in breast cancer survivors
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy